It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
BACKGOUND: The aim of this study was to evaluate the safety and practicality of very early
(within 48 h) discharge with long-term follow-up results, and to define an optimal length of
stay in hospital for patients with ST elevation myocardial infarction (STEMI) according to
their demographic characteristics and risk assessment.
METHODS: A total of 267 patients with STEMI successfully treated with primary coronary intervention
were retrospectively analyzed. Patients was divided into four groups according to length of
hospitalization: 24 hours, 48 hours, 72 hours, and more than 72 hours. The groups were compared
in terms of the patients’ demographic and clinical characteristics, short- and long-term follow-up
results, mortality, revascularization and major adverse cardiac events (MACE).
RESULTS: More than two thirds of the patients were discharged within 48 hours (68.9%). No
difference was observed between groups in terms of one month and one year MACE and one
year restenosis. However, one month restenosis was slightly higher in the fourth group. At the
end of the first year, there had been only four deaths, and these were in the third and fourth
groups. There were no deaths among patients discharged within 48 hours. Killip class, left
ventricular ejection fraction, multi-vessel disease and diabetes were the major determinants of
length of stay in hospital.
CONCLUSIONS: Very early discharge is safe and feasible and does not increase the mortality
rate. Uncomplicated STEMI patients with single vessel disease could be discharged after
24 hours. Patients with multi-vessel disease classified in the low risk group could be discharged
after 48 hours. (Cardiol J 2011; 18, 4: 378–384)
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer